Literature DB >> 21841499

Determinants of masked hypertension in the general population: the Finn-Home study.

Marjo-Riitta A Hänninen1, Teemu J Niiranen, Pauli J Puukka, Aino K Mattila, Antti M Jula.   

Abstract

INTRODUCTION: Home blood pressure (BP) measurement has allowed the identification of individuals with normal office and elevated out-of-office BP (masked hypertension). It is, however, not feasible to measure home BP on all office normotensive individuals. The objective of the present study was to identify demographic, lifestyle, clinical and psychological characteristics suggestive of masked hypertension.
METHODS: Study population was drawn from the participants of a multidisciplinary epidemiological survey, the Health 2000 Study. The untreated nationwide population sample (n = 1459, age 45-74 years) underwent office (duplicate measurements on one visit) and home (duplicate measurements on 7 days) BP measurements and risk factor evaluation. Psychometric tests assessed psychological distress, hypochondriasis, depression and alexithymia. Masked hypertension was defined as normal office BP (<140/90 mmHg) with elevated home BP (≥135/85 mmHg).
RESULTS: The prevalence of masked hypertension was 8.1% in the untreated Finnish adult population. The cardiovascular risk profile of masked hypertensive patients resembled that of sustained hypertensive patients. High-normal systolic and diastolic office BP, older age, greater BMI, current smoking, excessive alcohol consumption, diabetes and electrocardiographic left-ventricular hypertrophy were independent determinants of masked hypertension in multivariate logistic regression analysis. Masked hypertension was also independently associated with hypochondria.
CONCLUSION: Masked hypertension is a common phenomenon in an untreated adult population. Physicians should consider home BP measurement if a patient has high-normal office BP, diabetes, left-ventricular hypertrophy, or several other conventional cardiovascular risk factors.

Entities:  

Mesh:

Year:  2011        PMID: 21841499     DOI: 10.1097/HJH.0b013e32834a98ba

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  30 in total

Review 1.  The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Authors:  Sherilyn K D Houle; Raj Padwal; Luc Poirier; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2015-07

2.  Depression in hypertension and blood pressure variability over shorter time periods.

Authors:  Tomoyuki Kabutoya; Kazuomi Kario
Journal:  Hypertens Res       Date:  2015-08-20       Impact factor: 3.872

3.  Relationship between office and home blood pressure with increasing age: The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO).

Authors:  Angeliki Ntineri; George S Stergiou; Lutgarde Thijs; Kei Asayama; José Boggia; Nadia Boubouchairopoulou; Atsushi Hozawa; Yutaka Imai; Jouni K Johansson; Antti M Jula; Anastasios Kollias; Leonella Luzardo; Teemu J Niiranen; Kyoko Nomura; Takayoshi Ohkubo; Ichiro Tsuji; Christophe Tzourio; Fang-Fei Wei; Jan A Staessen
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

4.  Are personality traits associated with white-coat and masked hypertension?

Authors:  Antonio Terracciano; Angelo Scuteri; James Strait; Angelina R Sutin; Osorio Meirelles; Michele Marongiu; Marco Orru; Maria Grazia Pilia; Luigi Ferrucci; Francesco Cucca; David Schlessinger; Edward Lakatta
Journal:  J Hypertens       Date:  2014-10       Impact factor: 4.844

5.  Metabolic risk factors and masked hypertension in the general population: the Finn-Home study.

Authors:  M-Ra Hänninen; T J Niiranen; P J Puukka; A M Jula
Journal:  J Hum Hypertens       Date:  2014-01-02       Impact factor: 3.012

6.  Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study.

Authors:  Samantha G Bromfield; Daichi Shimbo; John N Booth; Adolfo Correa; Gbenga Ogedegbe; April P Carson; Paul Muntner
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

7.  Orthostatic hypertension as a predisposing factor for masked hypertension: the J-SHIPP study.

Authors:  Yasuharu Tabara; Michiya Igase; Tetsuro Miki; Yasumasa Ohyagi; Fumihiko Matsuda; Katsuhiko Kohara
Journal:  Hypertens Res       Date:  2016-06-16       Impact factor: 3.872

Review 8.  The complexity of masked hypertension: diagnostic and management challenges.

Authors:  Stanley S Franklin; Nathan D Wong
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 9.  Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.

Authors:  J Peacock; K M Diaz; A J Viera; J E Schwartz; D Shimbo
Journal:  J Hum Hypertens       Date:  2014-02-27       Impact factor: 3.012

10.  Outcomes from a community-based hypertension educational programme: the West of Ireland Hypertension study.

Authors:  M Darrat; A Houlihan; I Gibson; M Rabbitt; G Flaherty; F Sharif
Journal:  Ir J Med Sci       Date:  2017-11-06       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.